SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%Nov 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PeterR1700 who wrote (17593)3/18/1998 10:01:00 AM
From: Henry Niman  Read Replies (2) of 32384
 
Peter, LGND (and analysts) expect LGND to be profitable next year (Bear Stearns says $0.09). LGND should file its Panretin topical NDA this month. Their partners should enter several compounds into the clinic this year, triggering milestones including AHP's TSE424 this month. NDA filings for Targretin Topical and Oral are also expected this year (or very beginning of next year). LGND is starting to pull out. Time to hop on board.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News